Видео ютуба по тегу Immunity Bio

What to know about Anktiva, the cancer drug that doesn’t use chemotherapy | Killing Cancer
What to know about Anktiva, the cancer drug that doesn’t use chemotherapy | Killing Cancer
ImmunityBio (IBRX) Is Becoming a Sleeping Giant - And Patrick Soon Shiong Knows It
ImmunityBio (IBRX) Is Becoming a Sleeping Giant - And Patrick Soon Shiong Knows It
Dr. Patrick Soon-Shiong - “Truth and Trust” in Cancer Research & Journalism | The Daily Show
Dr. Patrick Soon-Shiong - “Truth and Trust” in Cancer Research & Journalism | The Daily Show
ANKTIVA: Did the FDA Block a Life Saving Cure? Let’s Fact Check! | Cancer Immunotherapy
ANKTIVA: Did the FDA Block a Life Saving Cure? Let’s Fact Check! | Cancer Immunotherapy
Is IBRX a Hidden Biotech Gem? ImmunityBio Stock Catalysts & Pipeline Breakdown
Is IBRX a Hidden Biotech Gem? ImmunityBio Stock Catalysts & Pipeline Breakdown
ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming Bladder Cancer Treatment
ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming Bladder Cancer Treatment
This One Injection will KILL CANCER - Billionaire Dr. Patrick Soon Shiong
This One Injection will KILL CANCER - Billionaire Dr. Patrick Soon Shiong
Next-Generation Immunotherapy for NMIBC: QUILT 2.005 and QUILT 3.032
Next-Generation Immunotherapy for NMIBC: QUILT 2.005 and QUILT 3.032
ESMO25: Harnessing the innate and the adaptive immune response, with Dr Sandeep Reddy
ESMO25: Harnessing the innate and the adaptive immune response, with Dr Sandeep Reddy
Discover ASCO 2025: Lymphopenia, Immunity & Bioshield
Discover ASCO 2025: Lymphopenia, Immunity & Bioshield
2024 Walk to End Bladder Cancer - ImmunityBio San Diego, CA
2024 Walk to End Bladder Cancer - ImmunityBio San Diego, CA
Hoag Hospital Tapped As Only Site For First Phase Of ImmunityBio & NantKwest COVID-19 Vaccine Trial
Hoag Hospital Tapped As Only Site For First Phase Of ImmunityBio & NantKwest COVID-19 Vaccine Trial
ImmunityBio stock analysis - would ChatGPT buy or sell today? [May 2025]
ImmunityBio stock analysis - would ChatGPT buy or sell today? [May 2025]
ImmunityBio’s Pipeline Is Loaded - And These Catalysts Could Send IBRX Soaring
ImmunityBio’s Pipeline Is Loaded - And These Catalysts Could Send IBRX Soaring
ImmunityBio (IBRX): Explosive ANKTIVA growth, rising oncology pipeline momentum...
ImmunityBio (IBRX): Explosive ANKTIVA growth, rising oncology pipeline momentum...
Physician's Journey
Physician's Journey
The Secret Biotech Billionaire Behind ImmunityBio (IBRX) Revealed
The Secret Biotech Billionaire Behind ImmunityBio (IBRX) Revealed
ImmunityBio (IBRX) From Bladder Cancer to Lung Cancer: The Expanding Potential of ANKTIVA
ImmunityBio (IBRX) From Bladder Cancer to Lung Cancer: The Expanding Potential of ANKTIVA
Dr. Patrick Soon-Shiong Discusses New Middle East Cancer BioShield Platform, Done With Saudi Arabia
Dr. Patrick Soon-Shiong Discusses New Middle East Cancer BioShield Platform, Done With Saudi Arabia
ImmunityBio (IBRX) Building a Biotech MOAT with Game-Changing Cancer Therapies
ImmunityBio (IBRX) Building a Biotech MOAT with Game-Changing Cancer Therapies
My Key Takeaway from ImmunityBio's Latest Business Update
My Key Takeaway from ImmunityBio's Latest Business Update
FDA declines to approve ImmunityBio's bladder cancer therapy, shares slump|#shorts
FDA declines to approve ImmunityBio's bladder cancer therapy, shares slump|#shorts
ImmunityBio stock analysis - would ChatGPT buy or sell today? [May 2025]
ImmunityBio stock analysis - would ChatGPT buy or sell today? [May 2025]
ImmunityBio (IBRX): A Hidden Gem Backed by Patrick Soon Shiong’s Proven Track Record
ImmunityBio (IBRX): A Hidden Gem Backed by Patrick Soon Shiong’s Proven Track Record